Minireviews
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Ophthalmol. Nov 12, 2013; 3(4): 32-37
Published online Nov 12, 2013. doi: 10.5318/wjo.v3.i4.32
Melatonin and derivatives as promising tools for glaucoma treatment
Hanan Awad Alkozi, Jesús Pintor
Hanan Awad Alkozi, Jesús Pintor, Department of Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, Universidad Complutense de Madrid, E-28037 Madrid, Spain
Author contributions: Alkozi HA and Pintor J contributed equally to this work.
Supported by Universidad Complutense de Madrid, No. GR35/10-A-920777; the Ministry of Economy, No. SAF 2010/16024; the Institute Carlos III, No. RETICS RD12/0034/0003
Correspondence to: Jesús Pintor, Professor, Department of Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, Universidad Complutense de Madrid, c/Arcos de Jalón 118, E-28037 Madrid, Spain. jpintor@ucm.es
Telephone: +34-91-3946859 Fax: +34-91-3946885
Received: August 21, 2013
Revised: November 5, 2013
Accepted: November 10, 2013
Published online: November 12, 2013
Core Tip

Core tip: This mini review depicts the main features of melatonin and derivatives as interesting agents for the treatment of the ocular hypertension associated with glaucoma.